205 related articles for article (PubMed ID: 11087237)
1. PR-39, a potent neutrophil inhibitor, attenuates myocardial ischemia-reperfusion injury in mice.
Hoffmeyer MR; Scalia R; Ross CR; Jones SP; Lefer DJ
Am J Physiol Heart Circ Physiol; 2000 Dec; 279(6):H2824-8. PubMed ID: 11087237
[TBL] [Abstract][Full Text] [Related]
2. PR-39 and PR-11 peptides inhibit ischemia-reperfusion injury by blocking proteasome-mediated I kappa B alpha degradation.
Bao J; Sato K; Li M; Gao Y; Abid R; Aird W; Simons M; Post MJ
Am J Physiol Heart Circ Physiol; 2001 Dec; 281(6):H2612-8. PubMed ID: 11709430
[TBL] [Abstract][Full Text] [Related]
3. The receptor for activated complement factor 5 (C5aR) conveys myocardial ischemic damage by mediating neutrophil transmigration.
Mueller M; Herzog C; Larmann J; Schmitz M; Hilfiker-Kleiner D; Gessner JE; Theilmeier G
Immunobiology; 2013 Sep; 218(9):1131-8. PubMed ID: 23642836
[TBL] [Abstract][Full Text] [Related]
4. Peroxynitrite inhibits leukocyte-endothelial cell interactions and protects against ischemia-reperfusion injury in rats.
Lefer DJ; Scalia R; Campbell B; Nossuli T; Hayward R; Salamon M; Grayson J; Lefer AM
J Clin Invest; 1997 Feb; 99(4):684-91. PubMed ID: 9045871
[TBL] [Abstract][Full Text] [Related]
5. PR-39, a proline/arginine-rich antimicrobial peptide, exerts cardioprotective effects in myocardial ischemia-reperfusion.
Ikeda Y; Young LH; Scalia R; Ross CR; Lefer AM
Cardiovasc Res; 2001 Jan; 49(1):69-77. PubMed ID: 11121797
[TBL] [Abstract][Full Text] [Related]
6. Vitamin E attenuates myocardial ischemia-reperfusion injury in murine AIDS.
Chen Y; Davis-Gorman G; Watson RR; McDonagh PF
Cardiovasc Toxicol; 2002; 2(2):119-27. PubMed ID: 12271155
[TBL] [Abstract][Full Text] [Related]
7. Perflubron emulsion prevents PMN activation and improves myocardial functional recovery after cold ischemia and reperfusion.
Gale SC; Gorman GD; Copeland JG; McDonagh PF
J Surg Res; 2007 Mar; 138(1):135-40. PubMed ID: 17173933
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effects of N,N,N-trimethylsphingosine following ischemia and reperfusion in the isolated perfused rat heart.
Campbell B; Shin YK; Scalia R; Lefer AM
Cardiovasc Res; 1998 Aug; 39(2):393-400. PubMed ID: 9798524
[TBL] [Abstract][Full Text] [Related]
9. Soluble complement receptor type 1 inhibits the complement pathway and prevents contractile failure in the postischemic heart. Evidence that complement activation is required for neutrophil-mediated reperfusion injury.
Shandelya SM; Kuppusamy P; Herskowitz A; Weisfeldt ML; Zweier JL
Circulation; 1993 Dec; 88(6):2812-26. PubMed ID: 8252695
[TBL] [Abstract][Full Text] [Related]
10. Cardioprotection by a novel recombinant serine protease inhibitor in myocardial ischemia and reperfusion injury.
Murohara T; Guo JP; Lefer AM
J Pharmacol Exp Ther; 1995 Sep; 274(3):1246-53. PubMed ID: 7562495
[TBL] [Abstract][Full Text] [Related]
11. The endothelin A receptor antagonist LU 135252 protects the myocardium from neutrophil injury during ischaemia/reperfusion.
Gonon AT; Wang QD; Pernow J
Cardiovasc Res; 1998 Sep; 39(3):674-82. PubMed ID: 9861311
[TBL] [Abstract][Full Text] [Related]
12. Myocardial and endothelial protection by TMS in ischemia-reperfusion injury.
Murohara T; Buerke M; Margiotta J; Ruan F; Igarashi Y; Hakomori S; Lefer AM
Am J Physiol; 1995 Aug; 269(2 Pt 2):H504-14. PubMed ID: 7544541
[TBL] [Abstract][Full Text] [Related]
13. The effect of C1 inhibitor on myocardial ischemia and reperfusion injury.
Lu F; Fernandes SM; Davis AE
Cardiovasc Pathol; 2013; 22(1):75-80. PubMed ID: 22705194
[TBL] [Abstract][Full Text] [Related]
14. Cardioprotective effects of the serine protease inhibitor aprotinin after regional ischemia and reperfusion on the beating heart.
Pruefer D; Buerke U; Khalil M; Dahm M; Darius H; Oelert H; Buerke M
J Thorac Cardiovasc Surg; 2002 Nov; 124(5):942-9. PubMed ID: 12407377
[TBL] [Abstract][Full Text] [Related]
15. Simvastatin preserves the ischemic-reperfused myocardium in normocholesterolemic rat hearts.
Lefer AM; Campbell B; Shin YK; Scalia R; Hayward R; Lefer DJ
Circulation; 1999 Jul; 100(2):178-84. PubMed ID: 10402448
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibody to L-selectin attenuates neutrophil accumulation and protects ischemic reperfused cat myocardium.
Ma XL; Weyrich AS; Lefer DJ; Buerke M; Albertine KH; Kishimoto TK; Lefer AM
Circulation; 1993 Aug; 88(2):649-58. PubMed ID: 7687936
[TBL] [Abstract][Full Text] [Related]
17. Cardioprotective actions of a monoclonal antibody against CD-18 in myocardial ischemia-reperfusion injury.
Lefer DJ; Shandelya SM; Serrano CV; Becker LC; Kuppusamy P; Zweier JL
Circulation; 1993 Oct; 88(4 Pt 1):1779-87. PubMed ID: 8104739
[TBL] [Abstract][Full Text] [Related]
18. Single administration of the CXC chemokine-binding protein Evasin-3 during ischemia prevents myocardial reperfusion injury in mice.
Montecucco F; Lenglet S; Braunersreuther V; Pelli G; Pellieux C; Montessuit C; Lerch R; Deruaz M; Proudfoot AE; Mach F
Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1371-7. PubMed ID: 20413731
[TBL] [Abstract][Full Text] [Related]
19. Peroxynitrite reduces myocardial infarct size and preserves coronary endothelium after ischemia and reperfusion in cats.
Nossuli TO; Hayward R; Scalia R; Lefer AM
Circulation; 1997 Oct; 96(7):2317-24. PubMed ID: 9337206
[TBL] [Abstract][Full Text] [Related]
20. A novel sialyl LewisX analog attenuates neutrophil accumulation and myocardial necrosis after ischemia and reperfusion.
Lefer DJ; Flynn DM; Phillips ML; Ratcliffe M; Buda AJ
Circulation; 1994 Nov; 90(5):2390-401. PubMed ID: 7525107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
